Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways

Erstveröffentlichung

2021

Authors

Edelmann, Jennifer

Dokal, Arran D.

Vilventhraraja, Emma

Holzmann, Karlheinz

Britton, David

et al.

Wissenschaftlicher Artikel

Published in

iScience ; 24 (2021), 2. - Art.-Nr. 102089. - eISSN 2589-0042

Link to publication

https://dx.doi.org/10.1016/j.isci.2021.102089

Faculties

Medizinische Fakultät

Institutions

Core Facility Genomics
UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: CHRONIC LYMPHOCYTIC-LEUKEMIA | ALPHA CONVERTING-ENZYME | SERINE PHOSPHORYLATION | CD20 EXPRESSION | IN-VITRO | SURVIVAL | ANTIBODY | MUTATIONS | activation | RELEASE
[DDC subject group]: DDC 570 / Life sciences | DDC 610 / Medicine & health

Metadata

Show full item record